[Subject to FRE 408 and Other Similar Rules ConfidentialExchange Offer Term Sheet (Cont.)New Money Oversubscription Right Each bondholder participating in the new money investment shall have the right to subscribe to additional amounts in excess of its pro rata allocation Oversubscription Amount: 3.0]
[By order of the Board China Southern Airlines Company Limited Xie Bing Company Secretary Guangzhou, the Peoples Republic of China 29 June 2020 non-executive As at the date of this announcement, the Directors include Wang Chang Shun, Ma Xu Lun and Han Wen Sheng as executive Directors; and Zheng Fan,]
[By order of the Board China Southern Airlines Company Limited Xie Bing Company Secretary Guangzhou, the Peoples Republic of China 29 June 2020 non-executive As at the date of this announcement, the Directors include Wang Chang Shun, Ma Xu Lun and Han Wen Sheng as executive Directors; and Zheng Fan,]
[Termination agreement of “Exclusive Business Cooperation Agreement,” “Exclusive Option Agreement,” “Share Pledge Agreement,” “Timely Reporting Agreement,” and “Powers of Attorney” Agreement Parties This Termination Agreement (the “ Hao Limo (1) Hao Limo Technology (Beijing) Co., Ltd. (the “ Huamuche]
[Xunlei Announces $20 million Share Buyback Program SHENZHEN, China, June 29, 2020 — Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading innovator of shared cloud computing and blockchain technology in China, today announced that the board of directors of the Company has approved a p]
[Sinovac Reports Unaudited First Quarter 2020 Financial Results BEIJING, China, June 30, 2020 / Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the first q]
[FOR RELEASE June 29, 2020 China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction BEIJING, China – June 29, 2020 – China Biologic will continue to take all necessary measures and actions to protect its rights and recoup all potential losses due to Xinjiang Deyuan]
[FOR RELEASE June 29, 2020 China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction BEIJING, China – June 29, 2020 – China Biologic will continue to take all necessary measures and actions to protect its rights and recoup all potential losses due to Xinjiang Deyuan]
[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED ( A join t stoc k limite d compan y incorporate d i n th e People s Republi c o f Chin a wit h limite d liability) (Stock Code: 2628) ANNOUNCEMENT RESOLUTIONS PASSED AT THE ANNUAL GENERAL MEETING AND DISTRIBUTION OF FINAL DIVIDEND Board Board of Dir]
[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED ( A join t stoc k limite d compan y incorporate d i n th e People s Republi c o f Chin a wit h limite d liability) (Stock Code: 2628) ANNOUNCEMENT RESOLUTIONS PASSED AT THE ANNUAL GENERAL MEETING AND DISTRIBUTION OF FINAL DIVIDEND Board Board of Dir]
